Search Results - "Terzolo, M"

Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up by Fassnacht, M, Assie, G, Baudin, E, Eisenhofer, G, de la Fouchardiere, C, Haak, H R, de Krijger, R, Porpiglia, F, Terzolo, M, Berruti, A

Get full text

Subclinical Cushing's syndrome: definition and management by Terzolo, M., Pia, A., Reimondo, G.

“…Summary Subclinical Cushing’s syndrome is an ill‐defined endocrine disorder that may be observed in patients bearing an incidentally found adrenal adenoma. The…”
Get full text

AME Position Statement on adrenal incidentaloma by Terzolo, M, Stigliano, A, Chiodini, I, Loli, P, Furlani, L, Arnaldi, G, Reimondo, G, Pia, A, Toscano, V, Zini, M, Borretta, G, Papini, E, Garofalo, P, Allolio, B, Dupas, B, Mantero, F, Tabarin, A

“…ObjectiveTo assess currently available evidence on adrenal incidentaloma and provide recommendations for clinical practice.DesignA panel of experts (appointed…”
Get full text

Prognostic factors in stage III–IV adrenocortical carcinomas (ACC): an European Network for the Study of Adrenal Tumor (ENSAT) study by Libé, R., Borget, I., Ronchi, C.L., Zaggia, B., Kroiss, M., Kerkhofs, T., Bertherat, J., Volante, M., Quinkler, M., Chabre, O., Bala, M., Tabarin, A., Beuschlein, F., Vezzosi, D., Deutschbein, T., Borson-Chazot, F., Hermsen, I., Stell, A., Fottner, C., Leboulleux, S., Hahner, S., Mannelli, M., Berruti, A., Haak, H., Terzolo, M., Fassnacht, M., Baudin, E.

“…The clinical course of advanced adrenocortical carcinoma (ACC) is heterogeneous. Our study aimed primarily to refine and make headway in the prognostic…”
Get full text

New perspectives for mitotane treatment of adrenocortical carcinoma by Puglisi, S., Calabrese, A., Basile, V., Pia, A., Reimondo, G., Perotti, P., Terzolo, M.

“…Adrenocortical carcinoma (ACC) is an aggressive cancer characterized by poor survival. Apart from radical surgery, there is a limited range of therapeutic…”
Get full text

Predictors of morbidity and mortality in acromegaly: an Italian survey by Arosio, M, Reimondo, G, Malchiodi, E, Berchialla, P, Borraccino, A, De Marinis, L, Pivonello, R, Grottoli, S, Losa, M, Cannavò, S, Minuto, F, Montini, M, Bondanelli, M, De Menis, E, Martini, C, Angeletti, G, Velardo, A, Peri, A, Faustini-Fustini, M, Tita, P, Pigliaru, F, Borretta, G, Scaroni, C, Bazzoni, N, Bianchi, A, Appetecchia, M, Cavagnini, F, Lombardi, G, Ghigo, E, Beck-Peccoz, P, Colao, A, Terzolo, M

“…ObjectiveTo describe demographic and hormonal characteristics, comorbidities (diabetes mellitus and hypertension), therapeutic procedures and their…”
Get full text

S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study by Elhassan, Y S, Altieri, B, Berhane, S, Cosentini, D, Calabrese, A, Haissaguerre, M, Kastelan, D, Fragoso, M C B V, Bertherat, J, Al Ghuzlan, A, Haak, H, Boudina, M, Canu, L, Loli, P, Sherlock, M, Kimpel, O, Laganà, M, Sitch, A J, Kroiss, M, Arlt, W, Terzolo, M, Berruti, A, Deeks, J J, Libé, R, Fassnacht, M, Ronchi, C L

“…Objective Adrenocortical carcinoma (ACC) has an aggressive but variable clinical course. Prognostic stratification based on the European Network for the Study…”
Get full text

Management of adrenal cancer: a 2013 update by Terzolo, M., Daffara, F., Ardito, A., Zaggia, B., Basile, V., Ferrari, L., Berruti, A.

“…Adrenocortical carcinoma (ACC) is a devastating tumor for either patients or their families because of short life expectancy and severe impact on quality of…”
Get full text

Corrigendum to “Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology volume 31 (2020) 1476-1490] by Fassnacht, M., Assie, G., Baudin, E., Eisenhofer, G., Fouchardiere, C. de la, Haak, H.R., de Krijger, R., Porpiglia, F., Terzolo, M., Berruti, A.

Get full text

Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence by Calabrese, A, Basile, V, Puglisi, S, Perotti, P, Pia, A, Saba, L, Berchialla, P, Porpiglia, F, Veltri, A, Volante, M, Reimondo, G, Berruti, A, Terzolo, M

“…Objective Many patients with adrenocortical carcinoma (ACC) suffer from tumor recurrence despite radical surgery. Evidence on the post-operative use of…”
Get full text

Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review by Isidori, Andrea M, Sbardella, Emilia, Zatelli, Maria Chiara, Boschetti, Mara, Vitale, Giovanni, Colao, Annamaria, Pivonello, Rosario

“…Context: Ectopic Cushing's Syndrome (ECS) can be a diagnostic challenge with the hormonal source difficult to find. This study analyzes the accuracy of imaging…”
Get full text

Comparison of Two Mitotane Starting Dose Regimens in Patients With Advanced Adrenocortical Carcinoma by Kerkhofs, T. M, Baudin, E, Terzolo, M, Allolio, B, Chadarevian, R, Mueller, H. H, Skogseid, B, Leboulleux, S, Mantero, F, Haak, H. R, Fassnacht, M

“…Context: Mitotane is the only approved drug for treatment of adrenocortical carcinoma. Its pharmacokinetic properties are not fully elucidated and different…”
Get full text

Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection by Terzolo, M, Baudin, A E, Ardito, A, Kroiss, M, Leboulleux, S, Daffara, F, Perotti, P, Feelders, R A, deVries, J H, Zaggia, B, De Francia, S, Volante, M, Haak, H R, Allolio, B, Al Ghuzlan, A, Fassnacht, M, Berruti, A

“…ContextMitotane plasma concentrations ≥14 mg/l have been shown to predict tumor response and better survival in patients with advanced adrenocortical carcinoma…”
Get full text

Merits and pitfalls of mifepristone in Cushing's syndrome by Castinetti, F, Fassnacht, M, Johanssen, S, Terzolo, M, Bouchard, P, Chanson, P, Do Cao, C, Morange, I, Picó, A, Ouzounian, S, Young, J, Hahner, S, Brue, T, Allolio, B, Conte-Devolx, B

“…ObjectiveMifepristone is the only available glucocorticoid receptor antagonist. Only few adult patients with hypercortisolism were treated to date by this…”
Get full text

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series by Bovio, S, Cataldi, A, Reimondo, G, Sperone, P, Novello, S, Berruti, A, Borasio, P, Fava, C, Dogliotti, L, Scagliotti, G V, Angeli, A, Terzolo, M

“…Adrenal incidentalomas, defined as masses discovered incidentally during imaging investigation of non-adrenal disorders, have become a rather common finding in…”
Get full text

Disease control of acromegaly does not prevent excess mortality in the long term: results of a nationwide survey in Italy by Arosio, M., Sciannameo, V., Contarino, A., Berchialla, P., Puglisi, S., Pesatori, A. C., Ferrante, E., Filopanti, M., Pivonello, R., Dassie, F., Rochira, V., Cannavò, S., De Menis, E., Pigliaru, F., Grottoli, S., Cambria, V., Faustini-Fustini, M., Montini, M., Peri, A., Ceccato, F., Puxeddu, E., Borretta, G., Bondanelli, M., Ferone, D., Colao, A., Terzolo, M., Reimondo, G.

“…Objective This study aimed to assess the long-term outcome of patients with acromegaly. Design This is a multicenter, retrospective, observational study which…”
Get full text

May an adrenal incidentaloma change its nature? by Müller, A., Ingargiola, E., Solitro, F., Bollito, E., Puglisi, S., Terzolo, M., Pia, A., Reimondo, G.

“…Background Up to 70% of adrenal masses detected in patients affected by extra-adrenal malignancy are metastatic lesions. Therefore, detection of an adrenal…”
Get full text

What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study by Puglisi, S., Rossini, A., Tabaro, I., Cannavò, S., Ferrau’, F., Ragonese, M., Borretta, G., Pellegrino, M., Dughera, F., Parisi, A., Latina, A., Pia, A., Terzolo, M., Reimondo, G.

“…Purpose The impact of patient’s characteristics on glucocorticoid (GC) replacement therapy in adrenal insufficiency (AI) is poorly evaluated. Aims of this…”
Get full text

Insulin resistance is not coupled with defective insulin secretion in primary hyperparathyroidism by Tassone, F., Procopio, M., Gianotti, L., Visconti, G., Pia, A., Terzolo, M., Borretta, G.

“…Aims  An increased frequency of both impaired glucose tolerance and Type 2 diabetes mellitus (DM) has been reported in primary hyperparathyroidism (pHPT), thus…”
Get full text

Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE) by Stigliano, A, Chiodini, I, Giordano, R, Faggiano, A, Canu, L, Della Casa, S, Loli, P, Luconi, M, Mantero, F, Terzolo, M

Get full text